Compounds > lipoxin a4

lipoxin a4 and Neoplasms

lipoxin a4 has been researched along with Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Ahluwalia, K; Asante, I; Dave, P; Dong, T; Ebright, B; Epstein, AL; Humayun, M; Li, Z; Lin, T; Louie, SG; Mead, A; Pei, H; Petasis, NA; Salimova, M; Yoo, E; Zhou, E	1
Feng, Y; Li, N; Wang, K; Zhao, C; Zhao, L; Zhou, Y	1
Bielenberg, DR; Gartung, A; Gilligan, MM; Huang, S; Kieran, MW; Norris, PC; Panigrahy, D; Serhan, CN; Sukhatme, VP; Sulciner, ML	1
Bian, XW; Chen, K; Li, L; Su, S; Wang, JM; Xiang, Y; Yoshimura, T; Zhu, J	1
Cai, L; Chen, X; Chen, Y; Hao, H; He, S; Hoidal, J; Hu, S; Li, Y; Wu, P; Ye, D	1

Reviews

1 review(s) available for lipoxin a4 and Neoplasms

Article	Year
New development in studies of formyl-peptide receptors: critical roles in host defense. Journal of leukocyte biology, 2016, Volume: 99, Issue:3 Topics: Animals; Cell Movement; Chemotaxis; Humans; Inflammation; Leukocytes; Lipoxins; Macrophages; Neoplasms; Receptors, CCR7; Receptors, Formyl Peptide; Receptors, Interleukin-8B; Wound Healing	2016

Other Studies

4 other study(ies) available for lipoxin a4 and Neoplasms

Article	Year
NAP1051, a Lipoxin A4 Biomimetic Analogue, Demonstrates Antitumor Activity Against the Tumor Microenvironment. Molecular cancer therapeutics, 2021, Volume: 20, Issue:12 Topics: Animals; Biomimetics; Humans; Lipoxins; Male; Mice; Mice, Nude; Neoplasms; Transfection; Tumor Microenvironment	2021
Artesunate ameliorates osteoarthritis cartilage damage by updating MTA1 expression and promoting the transcriptional activation of LXA4 to suppress the JAK2/STAT3 signaling pathway. Human molecular genetics, 2023, 04-06, Volume: 32, Issue:8 Topics: Aggrecans; Animals; Artesunate; Cartilage; Chondrocytes; Collagen; Interleukin-1beta; Mice; Neoplasms; Osteoarthritis; Signal Transduction; Transcriptional Activation	2023
Aspirin-triggered proresolving mediators stimulate resolution in cancer. Proceedings of the National Academy of Sciences of the United States of America, 2019, 03-26, Volume: 116, Issue:13 Topics: Animals; Antineoplastic Agents; Aspirin; Chemokine CCL2; Chemokines; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Eicosanoids; Fatty Acids, Unsaturated; Female; Inflammation; Lipoxins; Macrophages; Metabolomics; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neoplasm Metastasis; Neoplasms; Nerve Tissue Proteins; Phagocytosis; Plasminogen Inactivators; Prostaglandins	2019
Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Molecular cancer therapeutics, 2010, Volume: 9, Issue:8 Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Screening Assays, Antitumor; Heptanoic Acids; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipoxins; Mice; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A	2010